The Conversation (0)
Valeant Pharmaceuticals Bumps Allergan takeover offer $54-billion
May. 29, 2014 11:25AM PST
Life Science Investing
Financial Post report that Valeant Pharmaceuticals International Inc.has upped it unsolicited offer for Botox-maker Allergan Inc. to nearly $54-billion. The company is putting more cash on the table as it tries to win investor support and get Allergan’s board to agree to talks.
Financial Post report that Valeant Pharmaceuticals International Inc.has upped it unsolicited offer for Botox-maker Allergan Inc. to nearly $54-billion. The company is putting more cash on the table as it tries to win investor support and get Allergan’s board to agree to talks.
Valeant chief executive Michael Pearson said:
Allergan shareholders want this deal to occur but they wanted a higher price. We think the revised offer we gave this morning addresses [investor] concerns.